Safety and efficacy of temsirolimus in combination with three different immuno-chemotherapy regimens in relapse and refractory mantle cell lymphoma, final results of the T3 phase IB trial of the LYSA.
Saved in:
| Title: | Safety and efficacy of temsirolimus in combination with three different immuno-chemotherapy regimens in relapse and refractory mantle cell lymphoma, final results of the T3 phase IB trial of the LYSA. |
|---|---|
| Authors: | Tessoulin, Benoît1,2 (AUTHOR), Bouabdallah, Kamal3 (AUTHOR), Burroni, Barbara4 (AUTHOR), Lamy, Thierry5 (AUTHOR), Gressin, Remy6 (AUTHOR), Cartron, Guillaume7 (AUTHOR), Thieblemont, Catherine8 (AUTHOR), Sarkozy, Clémentine9 (AUTHOR), Haioun, Corinne10 (AUTHOR), Casasnovas, Olivier11 (AUTHOR), Joubert, Clementine12 (AUTHOR), Gyan, Emmanuel13 (AUTHOR), Hermine, Olivier14 (AUTHOR), Le Gouill, Steven1,2,15 (AUTHOR) steven.legouill@chu-nantes.fr |
| Source: | Annals of Hematology. Aug2020, Vol. 99 Issue 8, p1771-1778. 8p. |
| Database: | Academic Search Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
Be the first to leave a comment!
